We are pleased to announce that the 17th Annual European Life Sciences CEO Forum (Sachs_ELSF) will take place on the 28th - 29th February 2024back at the Hilton Zurich Airport Hotel. The event will be part of the Sachs Spring Life Sciences Week, which will also incorporate the 5th Annual European HealthTech CEO Forum.
The success and longevity of the forum is built on the goodwill and repeat attendance of major corporate and financial investors, and pharma licensing executives and advisors, who are seeking to network with biotechs. The programme and presentations allow all to keep up with the latest industry developments and strategize for 2024.The physical programme will consist of the usual panels and keynotes, which will be available on demand from the 6th of March. Additionally, there will be pre-arranged in-person meetings, live and on demand company showcases and a reception. During the online week, virtual meetings will be available through the audio/video online meeting system.
The main programme for the 17th AnnualELSF is spread throughout 2 days (28th-29th of February) and will feature more than 12 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place indedicated presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate400+delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, banks and advisors with part of the audience participating virtually.
The In-Person meetings will be taking place on the 28th - 29th of February, while virtual meetings will take place on the 6th-8th of March. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect 1800+ meetings completed during SSLSW. The conference will be held in the Central European Time Zone and the programme will consist of:
Day 1 (Wednesday, 28th of February)
Industry Roundtable: Charting the Course for 2024
Investment Outlook for VC & PE Panel: Focusing on Current Portfolio & Additions
Cardiomet & Obesity Panel: Meeting the Huge Unmet Need
Rare & Orphan Therapies Panel: Gene Therapy & Other Modalities
Investing in NextGen ADC'S Panel
Neuro Advances Panel: Highlighting the Main Opportunities
Day 2 (Thursday, 29th of February)
Greater China Biopharma Panel: Potential Role in the European Life Science Industry
Pharma Dealmakers Panel: Viewing the Challenges from Both Sides
Oncology BD&L Panel: Keeping Pace with Market Needs
Cancer Progress Panel: Advances in Therapeutics & Radiopharmaceuticals
Early-Stage Investment Panel: Addressing the Funding Need
Rising Stars: Global Biotech Seed Session
In-Person Meetings –28th-29thof February Virtual Meetings via Online Meeting System –6th - 8th of March Networking Reception –28thof February On-Demand Content –from 6th of March
Confirmed Chairs & Speakers Include:
Alexander Gebauer, CEO, Galimedix
Andrea Malizia, CEO, IAMA Therapeutics S.r.l.
Andreas Jurgeit, Partner, Gimv
Andreas Wallnoefer, Partner, Jeito Capital
Anna Lisa Picciolo-Lehrke, Head Business Development Neurology, UCB Pharma
Antoine Boulanger, Senior Associate, Forbion
Aram Mangasarian, CEO, TME Pharma AG
Astrid Maria Dahl, COO and Head (Europe), Innovent Biologics (Europe) Limited
Christian Thomsen, Global Head, CNS BD&L, Boehringer Ingelheim International GmbH
Dani Bach, Partner, +ND Capital
Diana Saraceni, Co-Founder & General Partner, Panakès Partners SGR SpA
Ulrich Wendt, Global Head Business Development Immunology & Inflammation, Sanofi
Victoria English, Co-Founder & Editor, MedNous
To view the full list of speakers in 2023, please click here.
Complimentary passesareprovided for qualified institutional (buy/sell-side), private equity and venture investors. The number of passes is limited, and priority is given to regular participants, however the organiser has the discretion to reject registrations. Other participants may consider purchasing access, which includes in-person or virtual participation, with different options to showcase your company.
The Online Meeting System will open on the 13thof February for uploading profiles and sending meeting invites. The in-person meetings will be taking place on the 28th-29th of February, while virtual meetings will take place on the 6th - 8th of March. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings.
Presentations are a popular and useful way to gain additional exposure with potential investors and pharma partners, which make up over half the audience. We are pleased to announce that once again we will have 20-minute and 10-minutepresentations taking place in-person at the dedicated presenting tracks. Here you will be able to showcase your company in front of investors attending the physical event. The recording will be added to your company’s profile later, which will be available on demand for registered participants until the event portal closes. Start-up companies, which are looking for seed financing can apply for a Rising Stars – Seed Companies Session.
For those who are not able to present in-person, but are still interested to showcase their company, there is an option to purchase either a 20-minute or 10-minute presentation, which will be pre-recorded in advance and available to all registered attendees on the event’s portal. Start-up companies may also purchase a 5-minute pre-recorded showcase instead.
The Sachs Team can assist with the pre-recording of the presentation, or you can upload a video you already have. Interested viewers will be able to message or request a meeting with you using the Online Meeting System.
Presenters in 2023 Included:
Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at Sachs Spring Life Sciences Week is an effective way to gain leads, introduce new products and services, expand sales, and build relationships.
If you are attending the physical event, we have a limited number of tabletop exhibitions available at the venue, restricted to three companies. These exhibitions will be located in the 'Zurich A&B' room, where the registration, breaks, and the highest attendee traffic are concentrated.
For those who are not able to join the event or exhibit in-person, you could choose virtual exhibition package, which includes a dedicated virtual page, where we can upload your branded company’s profile and list ways to reach you, share video or images about services you provide and have files ready for download if you wish to share any additional information with potential clients.
If interested in learning more about exhibition options, please fill in the registration form.
There are a limited number of sponsorship opportunities for the forum, which include speaking, advertising, and branding options. Sponsors typically include investment banks and funds, large pharma, technology companies and service providers, including Stock Exchanges, IR companies, CROs, international lawyers and consulting companies. Tailored packages are available upon request. You can view the latest event’s sponsors here.
To learn more about presenting, exhibition or sponsorship opportunities, please fill in registration form or contact us at SachsTeam@SachsForum.com or by phone + 44 (0)203 463 4890.
Silver Sponsor in 2023:
Bronze Sponsors in 2023:
Contributing Sponsors in 2023:
Participating Pharmas in 2023:
Financial, Advisory & Investors Attending in 2023:
+NDCapital 3B Future Health Ventures AbbVie Ventures Abingworth LLP AFK & Partners Asset Management LLC AGTC Ventures LLC AMR Action Fund GP GmbH Anchor Andera Partners Apollo Health Ventures ARTO AG ATGN Consulting Atlas Capital Markets Atlas Capital Ventures LLC AXA Investment Managers BERNINA BioInvest Ltd. BGV (BioGeneration Ventures) BioMedPartners AG BiomedVC AG Bioqube Ventures BIOSTART Consulting GmbH Boehler Life Science Advice Bootstrap Europe Bpifrance Breslin AG & LSFA BROTHERS & Partners Europe Canica Holding AG Capricorn Partners CD-Venture GmbH Columbus Venture Partners Convergence Partners AG Corinthian Financial Management SARL Delin Ventures Digital Networks Plc. S.r.l. Eliraz Ventures Forbion Forty51 Ventures FutuRx Gimv Global Life Science Ventures GmbH GrayBella Capital LLC H.C. Wainwright & Co., LLC HBM Partners AG High-Tech Gründerfonds Management GmbH Hitachi Ventures GmbH HitchinRock Advisors Limited ICF Consult Switzerland Indaco Venture Partners SGR Indaco Venture Partners SGR S.p.A. Industrifonden Inflexion Private Equity Partners Inveready